Search

everythinglearnresearchcommunity

for

Search:↓

Promising cancer treatments were found, but the manufacturer closed.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Lymphocytic mural folliculitis in cats might be an early sign of pancreatic cancer.

A rare pancreatic tumor caused a woman's male-like features, treated successfully with surgery and medication.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Biological therapy boosts the immune system to effectively fight melanoma.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

SHBG binding properties are unchanged in male liver cirrhosis patients.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

More research is needed to understand chemotherapy-induced hair loss and its phases.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Women with PCOS often have liver disease, so liver health checks are important for them.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Mitotane changes steroid breakdown, affecting cortisol availability.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

HSA nanoparticles can improve tamoxifen delivery for breast cancer treatment, reducing side effects.